<?xml version="1.0" encoding="UTF-8"?>
<p id="p0145">As reviewed by Dr In-Kyu Yoon (International Vaccine Institute, South Korea), Dr Christopher Nelson (SanofiPasteur, Lyon, France) and Dr Annelies Wilder-Smith, major advances in dengue research have resulted in development of new vaccines that show promise for use in dengue prevention, such as Sanofi Pasteur’s recently licensed CYD-TDV (
 <italic>Dengvaxia</italic>®, Sanofi Pasteur, Lyon, France) and six other dengue vaccine candidates in various phases of clinical trials.
</p>
